SEC Form 4 · accession 0001209191-15-021181
CRESCENT BIOPHARMA, INC. · CBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian M. Hahn
Officer — CFO
Period of report
Feb 27, 2015
Accepted (ET)
Mar 3, 2015 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001253689
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2015 | M | 5,000 | $1.12 | A | 14,085 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.12 | Feb 27, 2015 | M | 5,000 | D | — | Jan 4, 2021 | Common Stock | 5,000 | 10,520 | D |
Explanation of responses
- F1Fully vested and exercisable.